These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28631773)

  • 1. [Cardiovascular complications of cancer chemotherapy. The need for cardio-oncology.].
    Dolara A
    Recenti Prog Med; 2017 Jun; 108(6):261-264. PubMed ID: 28631773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
    Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM
    J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.
    Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F
    Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular side-effects of modern cancer therapy.
    Minami M; Matsumoto S; Horiuchi H
    Circ J; 2010 Sep; 74(9):1779-86. PubMed ID: 20716834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving paediatric cardiologists' awareness about the needs of childhood cancer survivors: results of a single-centre directed educational initiative.
    Rose-Felker K; Effinger K; Kelleman MS; Sachdeva R; Meacham LR; Border WL
    Cardiol Young; 2019 Jun; 29(6):808-812. PubMed ID: 31280730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.
    Liang Z; He Y; Hu X
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular complications of chemotherapy].
    Tovena DM; Inzoli A; Donato G; Gazzaniga P; Bianchessi C
    G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):165S-170S. PubMed ID: 23096398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity: anthracyclines and long term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer treatment-related cardiovascular disease: Current status and future research priorities.
    Nonaka M; Hosoda H; Uezono Y
    Biochem Pharmacol; 2021 Aug; 190():114599. PubMed ID: 33989656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on cardio-oncology.
    Herrmann J; Lerman A
    Trends Cardiovasc Med; 2014 Oct; 24(7):285-95. PubMed ID: 25153017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioncology: state of the heart.
    Todaro MC; Oreto L; Qamar R; Paterick TE; Carerj S; Khandheria BK
    Int J Cardiol; 2013 Sep; 168(2):680-7. PubMed ID: 23639459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drugs cardiotoxicity].
    Capilla E; Poyet R; Brocq FX; Pons F; Kerebel S; Jego C; Laurent P; Cellarier GR
    Presse Med; 2015 Oct; 44(10):995-1002. PubMed ID: 26153088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of new and emerging cancer drugs: what the cardiologist needs to know.
    Fabiani I; Chianca M; Aimo A; Emdin M; Dent S; Fedele A; Cipolla CM; Cardinale DM
    Eur Heart J; 2024 Jun; 45(22):1971-1987. PubMed ID: 38591670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.
    Pituskin E; Paterson I; Cox-Kennett N; Rothe D; Perri M; Becher H
    Semin Oncol Nurs; 2017 Nov; 33(4):384-392. PubMed ID: 28941563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Why Cardio-Oncology Is Necessary Today - From a Viewpoint of the Tumor Internal Medicine].
    Ishioka C
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2048-2051. PubMed ID: 29361615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity: cisplatin and long-term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Jul; 175(1):201-2. PubMed ID: 24820740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.